<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03613142</url>
  </required_header>
  <id_info>
    <org_study_id>DTvsEG</org_study_id>
    <nct_id>NCT03613142</nct_id>
  </id_info>
  <brief_title>Comparison Between Double Tract Anastomosis and Esophagogastrostomy After Radical Proximal Gastrectomy</brief_title>
  <official_title>Comparison Between Double Tract Anastomosis and Esophagogastrostomy After Radical Proximal Gastrectomy: A Prospective, Randomized, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Cancer Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The patients with upper gastric cancer (cT1N0M0) or gastroesophageal adenocarcinoma (diameter
      less than 4 cm) will be enrolled into this study. Each of these patients will undergo radical
      proximal gastrectomy and be randomly allocated into one of the two groups, double tract
      anastomosis group or esophagogastrostomy group. The following data will be collected to
      compare the difference between the two reconstruction methods: the rate of reflux
      esophagitis, postoperative quality of life, economic expenditure, the safety of operation,
      postoperative recovery, postoperative nutrition status and oncological effect. Through the
      comprehensive analysis, the result of this study will elucidate the best of the
      reconstruction method after proximal gastrectomy.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of reflux esophagitis after operation</measure>
    <time_frame>12 months</time_frame>
    <description>The rate of reflux esophagitis after operation will be assessed by gastrointestinal endoscopy with Los Angeles (LA) classification. the degree of reflux esophagitis will be classified as N, A, B, C or D level, and latter levels represent a more severe reflux esophagitis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative quality of life</measure>
    <time_frame>12months</time_frame>
    <description>Assessed by European Organization for Research and Treatment of Cancer (EORTC) quality of life questionnaire (QLQ) - C30 questionnaire, the total score ranges from 30 to 126, and higher values represent a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative quality of life</measure>
    <time_frame>12months</time_frame>
    <description>Assessed by European Organization for Research and Treatment of Cancer (EORTC) quality of life questionnaire (QLQ) - STO22 questionnaire, the total score ranges from 22 to 88, and higher values represent a worse outcome.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">202</enrollment>
  <condition>Gastric Cancer</condition>
  <condition>GastroEsophageal Cancer</condition>
  <arm_group>
    <arm_group_label>Double tract anatomosis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After the proximal gastrectomy, the purse-string suture is tied at the esophagus stump, and the anvil head is inserted into the esophagus stump using an anvil clamp. A Roux-en-Y esophagojejunostomy (E-stomy) is performed by intracorporeal anastomosis with a circular stapler, and the jejunal stump is closed with a linear stapler. Next, side-to-side gastrojejunostomy (G-stomy), 15 cm below the E-stomy, is performed using 2 linear staplers. Finally, end-to-side jejunojejunostomy (J-stomy), 20 cm below the G-stomy, is performed by 2 linear staplers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Esophagogastrostomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After the proximal gastrectomy, the purse-string suture is tied at the esophagus stump, and the anvil head is inserted into the esophagus stump using an anvil clamp. Next, end-to-end or side to end esophagogastrostomy is performed with a circular stapler.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Double tract anatomosis</intervention_name>
    <description>After the proximal gastrectomy, the purse-string suture is tied at the esophagus stump, and the anvil head is inserted into the esophagus stump using an anvil clamp. A Roux-en-Y esophagojejunostomy (E-stomy) is performed by intracorporeal anastomosis with a circular stapler, and the jejunal stump is closed with a linear stapler. Next, side-to-side gastrojejunostomy (G-stomy), 15 cm below the E-stomy, is performed using 2 linear staplers. Finally, end-to-side jejunojejunostomy (J-stomy), 20 cm below the G-stomy, is performed by 2 linear staplers.</description>
    <arm_group_label>Double tract anatomosis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Esophagogastrostomy</intervention_name>
    <description>After the proximal gastrectomy, the purse-string suture is tied at the esophagus stump, and the anvil head is inserted into the esophagus stump using an anvil clamp. Next, end-to-end or side to end esophagogastrostomy is performed with a circular stapler.</description>
    <arm_group_label>Esophagogastrostomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients diagnosed as gastric or esophagogastric adenocarcinoma

          2. Age ranges from 18 to 80

          3. Karnofsky assessment no less than 70

          4. Completion of abdominal CT scan and ultrasound endoscopy

          5. Upper gastric cancer (cT1N0M0) or esophagogastric adenocarcinoma (diameter no more
             than 4 cm)

          6. radical proximal gastrectomy

          7. Normal blood routine examination and biochemical test

        Exclusion Criteria:

          1. Patients need to undergo total gastrectomy or distal gastrectomy

          2. Female patients with pregnancy

          3. Not suitable for operation

          4. Patients have already joined other clinical trials
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xin Ji, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Cancer Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xin Ji, M.D.</last_name>
    <phone>+86 18601201053</phone>
    <email>18601201053@126.com</email>
  </overall_contact>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>July 23, 2018</study_first_submitted>
  <study_first_submitted_qc>July 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2018</study_first_posted>
  <last_update_submitted>November 7, 2018</last_update_submitted>
  <last_update_submitted_qc>November 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Cancer Hospital</investigator_affiliation>
    <investigator_full_name>Biao Fan, MD</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Double tract</keyword>
  <keyword>Esophagogastrostomy</keyword>
  <keyword>Gastric cancer</keyword>
  <keyword>GastroEsophageal Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

